Realcan Pharmaceutical Group Co (SZSE:002589) Long-Term Capital Lease Obligation : ¥5 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Long-Term Capital Lease Obligation?

Realcan Pharmaceutical Group Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥5 Mil.

Realcan Pharmaceutical Group Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (¥1 Mil) to Dec. 2023 (¥1 Mil) but then increased from Dec. 2023 (¥1 Mil) to Mar. 2024 (¥5 Mil).

Realcan Pharmaceutical Group Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (¥39 Mil) to Dec. 2022 (¥3 Mil) and declined from Dec. 2022 (¥3 Mil) to Dec. 2023 (¥1 Mil).

Realcan Pharmaceutical Group Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Long-Term Capital Lease Obligation Chart

Realcan Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

16.05

39.19

2.73

0.84

Realcan Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															3.03	1.25	1.06	0.84	4.64

Realcan Pharmaceutical Group Co (SZSE:002589) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Realcan Pharmaceutical Group Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004

Website

http://www.realcan.cn

Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Executives

Zhang Ren Hua	Directors, executives
Han Xu	Director
Zhou Yun	Directors, Directors, and Executives
Wu Di	Executives
Su Li Chen	Executives
Wu Li Yan	Director
Tao Chun Fang	Supervisors
Han Song	Executives

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines